Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Diabetes, a disease in which carbohydrate and lipid metabolism are regulated improperly by insulin, is a serious worldwide health issue. Insulin is secreted from pancreatic beta cells in response to elevated plasma glucose, with various factors modifying its secretion. Free fatty acids (FFAs) provide an important energy source as nutrients, and they also act as signalling molecules in various cellular processes, including insulin secretion. Although FFAs are thought to promote insulin secretion in an acute phase, this mechanism is not clearly understood. Here we show that a G-protein-coupled receptor, GPR40, which is abundantly expressed in the pancreas, functions as a receptor for long-chain FFAs. Furthermore, we show that long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40. Our results indicate that GPR40 agonists and/or antagonists show potential for the development of new anti-diabetic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding and subsequent interaction of long-chain FFAs with the G-protein-coupled free fatty acid receptor (FFAR) 1 in the pancreatic β-cells leads to the activation of phospholipase C. PLC then hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) to diacylglycerol and inositol-1,4,5-triphosphate (IP3), with the latter docking on a calcium channel in the endoplasmic reticulum. The subsequent”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [94]
In the citing paper
“Activation of FFAR1 elevates [Ca2+]i and stimulates insulin secretion in a glucose-dependent fashion (306).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [306]
Citations
Cites
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,751
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · cited 1×
“MAP kinase MAP kinase activation in CHO and MIN6 cells after treatment with 10 µM of each FFA was determined as described previousl”
MethodSelf-citationCloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion
Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315
MIYAZAKI, J.-I., ARAKI, K., YAMATO, E., IKEGAMI, H., ASANO, T., SHIBASAKI, Y., OKA, Y., & YAMAMURA, K.-I. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,266
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201 · cited 1×
“Insulin is secreted from pancreatic β cells in response to elevated plasma glucose, with various factors modifying its secretio”
BackgroundThe Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104 · cited 1×
“Although it has been reported that FFAs activate GPR40 and that GPR40 is highly expressed in pancreatic β cell”
BackgroundFree Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus
BERGMAN, R., & ADER, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00323-4 · Cited by 622 · cited 1×
“: in short-term exposure, FFAs enhance GSIS but under long-term exposure they act to attenuate it; an effect called lipotoxicit”
BackgroundA prolactin-releasing peptide in the brain
Hinuma, S., Habata, Y., Fujii, R., Kawamata, Y., Hosoya, M., Fukusumi, S., Kitada, C., Masuo, Y., Asano, T., Matsumoto, H., et al. (1998) · Nature · doi:10.1038/30515 · Cited by 563 · cited 1×
“Previously, we established a strategy to identify ligands by detecting signal transductions in cells expressing orphan GPCR”
BackgroundSelf-citationMETABOLIC COUPLING FACTORS IN PANCREATIC β-CELL SIGNAL TRANSDUCTION
Newgard, C. B., & McGarry, J. D. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003353 · Cited by 531 · cited 1×
“Although several studies have proposed possible mechanisms for FFA-amplified GSIS—for example, that FFAs might simply provide energy to β cells or, alternatively, that the metabolites of FFAs, fatty acyl-coenzyme A molecules, act to stimulate insulin secretio”
BackgroundWank, S. A., Harkins, R., Jensen, R. T., Shapira, H., de Weerth, A., & Slattery, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3125 · Cited by 403 · cited 1×
“Its expression was comparable to that of type A cholecystokinin recepto”
Result
Cited by
Items 301–400 of 1,001
Simon-Szabó, L., Kokas, M., Mandl, J., Kéri, G., & Csala, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097868 · Cited by 93
“Glucose and FFA in turn synergistically stimulate insulin secretion [2] and a new steady state can be achieved at higher b-cell activity.”
BackgroundSong, F., Lu, S., Gunnet, J., Xu, J., Wines, P., Proost, J. C., Liang, Y. T., Baumann, C., Lenhard, J., Murray, W. V., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070130j · Cited by 96
Nagasaki, H., Kondo, T., Fuchigami, M., Hashimoto, H., Sugimura, Y., Ozaki, N., Arima, H., Ota, A., Oiso, Y., & Hamada, Y. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.01.001 · Cited by 93
Expression of free fatty acid receptor GPR40 in the neurogenic niche of adult monkey hippocampus
Ma, D., Lu, L., Boneva, N. B., Warashina, S., Kaplamadzhiev, D. B., Mori, Y., Nakaya, M., Kikuchi, M., Tonchev, A. B., Okano, H., et al. (2007) · Hippocampus · doi:10.1002/hipo.20393 · Cited by 103
“Although the mechanism of GPR40-mediated actions of free fatty acids is beginning to be uncovered in the pancreas (Itoh et al., 2003; Salehi et al., 2005; Nolan et al., 2006) and energy homeostasis (Covington et al., 2006), the function of GPR40 in the brain still 1Department of Restorative…”
20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1
Tunaru, S., Bonnavion, R., Brandenburger, I., Preussner, J., Thomas, D., Scholich, K., & Offermanns, S. (2018) · Nature Communications · doi:10.1038/s41467-017-02539-4 · Cited by 99
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist
Brown, S. P., Dransfield, P. J., Vimolratana, M., Jiao, X., Zhu, L., Pattaropong, V., Sun, Y., Liu, J., Luo, J., Zhang, J., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300133f · Cited by 93
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Paternoster, S., & Falasca, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00584 · Cited by 91
“GPR40 is primarily expressed by the pancreatic β-cells, where it plays a pivotal role in FFA-mediated insulin secretion (249) but also in α-cells (78, 250), CCK (80), GIP (251), and GLP-1 (79) producing cells in the gut and in hypothalamic neurons (248, 252, 253).”
BackgroundSasaki, S., Kitamura, S., Negoro, N., Suzuki, M., Tsujihata, Y., Suzuki, N., Santou, T., Kanzaki, N., Harada, M., Tanaka, Y., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101405t · Cited by 98
Self-citationPharmacophore-based virtual screening: a review of recent applications
Kim, K.-H., Kim, N. D., & Seong, B.-L. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003592072 · Cited by 89
“This receptor is highly expressed in the beta cells of pancreatic islets, and its activation by long-chain free fatty acids is known to enhance glucose-stimulated insulin secretion [87] .”
BackgroundThe Impact of Diet on Immunity and Respiratory Diseases
Wypych, T. P., Marsland, B. J., & Ubags, N. D. J. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201703-255aw · Cited by 103
What role do fat cells play in pancreatic tissue?
Gerst, F., Wagner, R. J., Oquendo, M. B., Siegel-Axel, D. I., Fritsche, A., Heni, M., Staiger, H., Häring, H., & Ullrich, S. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.001 · Cited by 100
Alexander, S., Mathie, A. A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_3.x · Cited by 93
Tikhonova, I. G., Sum, C. S., Neumann, S., Thomas, C. J., Raaka, B. M., Costanzi, S., & Gershengorn, M. C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0614782 · Cited by 97
Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
Sun, Q. L., Hirasawa, A., Hara, T., Kimura, I., Adachi, T., Awaji, T., Ishiguro, M., Suzuki, T., Miyata, N., & Tsujimoto, G. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066324 · Cited by 99
“FFAR1 is abundantly expressed in the pancreatic -cell, where it mediates FFA-enhanced glucosestimulated insulin secretion (Briscoe et al., 2003; Itoh et al., 2003; Poitout, 2003; Steneberg et al., 2005; Feng et al., 2006; Stoddart et al., 2008).”
BackgroundOh, D. Y., & Lagakos, W. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283479230 · Cited by 100
Nakamoto, K., Nishinaka, T., Sato, N., Mankura, M., Kōyama, Y., Kasuya, F., & Tokuyama, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081563 · Cited by 98
“Of these receptors, GPR40 is activated by long-chain fatty acids, such as DHA and EPA [14].”
BackgroundLi, X., Yu, Y., & Funk, C. D. (2013) · The FASEB Journal · doi:10.1096/fj.13-235333 · Cited by 97
Shen, W., Chuang, C., Martinez, K., Reid, T., Brown, J. M., Lin, X., Hixson, L., Hopkins, R. G., Starnes, J. W., & McIntosh, M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m030924 · Cited by 101
GPCR-Based Chemical Biosensors for Medium-Chain Fatty Acids
Mukherjee, K., Bhattacharyya, S., & Peralta‐Yahya, P. (2015) · ACS Synthetic Biology · doi:10.1021/sb500365m · Cited by 89
Treatment of Type 2 Diabetes by Free Fatty Acid Receptor Agonists
Watterson, K. R., Hudson, B. D., Ulven, T., & Milligan, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00137 · Cited by 97
“This is consistent with pre-clinical data demonstrating that Fasiglifam improved fasting hyperglycemia and glucose tolerance and augmented GSIS in diabetic rat models, with no hypoglycemia observed in normoglycemic rats (31).”
BackgroundInfluentialContribution of Oxidative Stress and Impaired Biogenesis of Pancreatic β-Cells to Type 2 Diabetes
Ježek, P., Jabůrek, M., & Plecitá‐Hlavatá, L. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7656 · Cited by 97
“The existence of FA-stimulated insulin secretion (FASIS) has not been widely recognized; despite it has been traditionally ascribed to the GPR40 pathway (96, 98, 248, 113, 122, 129, 139, 168, 171, 194, 235).”
InfluentialLinoleic acid and the regulation of glucose homeostasis: A review of the evidence
Hamilton, J., & Klett, E. L. (2021) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2021.102366 · Cited by 95
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1
Xiong, Y., Swaminath, G., Cao, Q., Li, Y., Guo, Q., Salomonis, H., Lu, J. Y.-L., Houze, J. B., Dransfield, P. J., Wang, Y., et al. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.009 · Cited by 96
Diakogiannaki, E., Dhayal, S., Childs, C. E., Calder, P. C., Welters, H. J., & Morgan, N. G. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0082 · Cited by 90
“…is noteworthy that some actions of fatty acids in b-cells are now attributed to the activation of a subgroup of G-protein-coupled receptors (GPRs; Itoh et al. 2003, Kotarsky et al. 2003, Fujiwara et al. 2005, Hardy et al. 2005, Salehi et al. 2005, Steneberg et al. 2005, Gromada 2006, Schnell et…”
BackgroundSoto-Guzmán, A., Robledo, T., Lopez-Pérez, M., & Salazar, E. P. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.003 · Cited by 96
Naik, H., Vakilynejad, M., Wu, J., Viswanathan, P., Dote, N., Higuchi, T., & Leifke, E. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011409230 · Cited by 88
Neurotrophin Signaling Is Required for Glucose-Induced Insulin Secretion
Houtz, J., Borden, P. M., Ceasrine, A. M., Minichiello, L., & Kuruvilla, R. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.10.003 · Cited by 96
Li, Z., Qiu, Q., Geng, X., Yang, J., Huang, W., & Qian, H. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1189530 · Cited by 90
Dietary fatty acids in gut health: Absorption, metabolism and function
Xu, E., Chen, C., Fu, J., Zhu, L., Shu, J., Jin, M., Wang, Y., & Zong, X. (2021) · Animal nutrition · doi:10.1016/j.aninu.2021.09.010 · Cited by 96
Identifying ligands at orphan GPCRs: current status using structure‐based approaches
Ngo, T., Kufareva, I., Coleman, J. L. J., Graham, R. M., Abagyan, R. A., & Smith, N. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13452 · Cited by 99
“The FFA1 receptor was deorphanized 6 years later via two independent screens of approximately 1000–1500 ligands, which demonstrated that long-chain free fatty acids (>C6) activated FFA1 receptors in [Ca2+] flux assays (Briscoe et al., 2003; Itoh et al., 2003).”
BackgroundUnderstanding the impact of taste changes in oncology care
Epstein, J. B., Smutzer, G., & Doty, R. L. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3083-8 · Cited by 90
“Others respond to touch and smell [70, 81].”
BackgroundExclusive photorelease of signalling lipids at the plasma membrane
Nadler, A., Yushchenko, D. A., Müller, R., Stein, F., Feng, S., Mulle, C., Carta, M., & Schultz, C. (2015) · Nature Communications · doi:10.1038/ncomms10056 · Cited by 87
Kato, M., Tani, T., Terahara, N., & Tsuda, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126157 · Cited by 86
“The coupling of GPR40/120 to the Gαq subunit leads to the IP3-mediated release of intracellular Ca 2+ [42, 44], whereas Gαs-coupled GPR119 and TGR5 stimulate GLP-1 secretion via the cAMP/protein kinase A (PKA)dependent pathway [43, 45].”
BackgroundLeifke, E., Naik, H., Wu, J., Viswanathan, P., DeManno, D., Kipnes, M., & Vakilynejad, M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.43 · Cited by 88
Luminal sensing in the gut: an overview.
Dockray, G. (2003) · PubMed · Cited by 86
Cen, J., Sargsyan, E., & Bergsten, P. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0119-5 · Cited by 86
“The mitochondria-independent action was via fatty acid metabolism and FFAR1/GPR40 signaling.”
BackgroundInfluentialDiscovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles
Wang, Y., Liu, J., Dransfield, P. J., Zhu, L., Wang, Z., Du, X., Jiao, X., Su, Y., Li, A., Brown, S. P., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300427u · Cited by 87
Filippis, A. D., Ullah, H., Baldi, A., Dacrema, M., Esposito, C., Garzarella, E. U., Santarcangelo, C., Tantipongpiradet, A., & Daglia, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144929 · Cited by 103
Olofsson, C. S., Salehi, A., Göpel, S. O., Holm, C., & Rorsman, P. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2836 · Cited by 85
Islet adaptation to insulin resistance: mechanisms and implications for intervention
Åhrén, B., & Pacini, G. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00361.x · Cited by 93
Wauquier, F., Philippe, C., Léotoing, L., Mercier, S., Davicco, M.-J., Lebecque, P., Guicheux, J., Pilet, P., Miot-Noirault, E., Poitout, V., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.429084 · Cited by 84
Potential role of skeletal muscle glucose metabolism on the regulation of insulin secretion
Mizgier, M. L., Casas, M., Contreras‐Ferrat, A., Llanos, P., & Galgani, J. E. (2014) · Obesity Reviews · doi:10.1111/obr.12166 · Cited by 82
“Long-chain fatty acids in the presence of high glucose concentrations can bind to G-protein-coupled receptor (GPR40), which induce intracellular calcium mobilization and subsequent stimulation of insulin secretion (25,26).”
BackgroundYashiro, H., Tsujihata, Y., Takeuchi, K., Hazama, M., Johnson, P. R. V., & Rorsman, P. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187708 · Cited by 84
Zhang, Q., Chen, L., Yang, H., Fang, Y., Wang, S., Wang, M., Yuan, Q., Wu, W. H., Zhang, Y., Liu, Z., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00825-y · Cited by 95
Ravnskjaer, K., Boergesen, M., Dalgaard, L. T., & Mandrup, S. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01965 · Cited by 84
“Fatty acids acutely potentiate glucose stimulated insulin secretion (Stein et al. 1996, Itoh et al. 2003, Roduit et al. 2004), whereas chronic exposure of -cells to elevated concentrations of fatty acids causes -cell dysfunction known as lipotoxicity (Shimabukuro et al. 1998b, Maedler et al. 2001).”
BackgroundTorii, K., Uneyama, H., & Nakamura, E. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0778-1 · Cited by 86
“A fatty acid receptor, GPR120, exists in both the oral cavity and the GI tract, and these acids interact with it to induce the release of circulating GLP-1 [48].”
InfluentialIslet β-cell failure in type 2 diabetes – Within the network of toxic lipids
Janikiewicz, J., Hanzelka, K., Koziński, K., Kolczyńska, K., & Dobrzyń, A. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.153 · Cited by 91
Varney, M. J., & Benovic, J. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001015 · Cited by 90
“Furthermore, pharmacologic and genetic inhibition of FFA1 in vitro abrogates FFA-mediated potentiation of GSIS (Itoh et al., 2003; Salehi et al., 2005; Briscoe et al., 2006).”
BackgroundG-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell
Morgan, N. G., & Dhayal, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.020 · Cited by 103
“negative [24]) but this view contrasts sharply with the findings of Flodgren et al.”
BackgroundResultInfluentialBharate, S. B., Nemmani, K. V. S., & Vishwakarma, R. A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770802665717 · Cited by 87
“Three independent groups [4-6] have identified GPR40 (FFA1) or FFA receptor (FFAR1) as a receptor for medium- (C6 – C12) and long-chain FFAs (C14 – C24).”
BackgroundStoddart, L. A., Brown, A. J., & Milligan, G. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031534 · Cited by 95
Structural basis for GPR40 allosteric agonism and incretin stimulation
Ho, J. D., Chau, B., Rodgers, L. A., Lu, F., Wilbur, K. L., Otto, K. A., Chen, Y., Song, M., Riley, J. P., Yang, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-01240-w · Cited by 84
Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity
Ježek, P., Jabůrek, M., Holendová, B., & Plecitá‐Hlavatá, L. (2018) · Molecules · doi:10.3390/molecules23061483 · Cited by 97
RGS4 is a negative regulator of insulin release from pancreatic β-cells in vitro and in vivo
de Azúa, I. R., Scarselli, M., Rosemond, E., Gautam, D., Jou, W., Gavrilova, O., Ebert, P. J., Levitt, P. R., & Wess, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003655107 · Cited by 86
“The two control siRNAs were targeted against the GPR40 receptor (16), another Gq-coupled receptor known to be expressed in pancreatic β-cells, or represented scrambled negative control siRNA (Ambion).”
BackgroundTRPA1 Is a Polyunsaturated Fatty Acid Sensor in Mammals
Motter, A. L., & Ahern, G. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038439 · Cited by 85
“Further, enteroendocrine tissue express several orphan GPCRs: GPR40 [6], GPR41 [7,8], GPR43 [7,8] and GPR120 [9] that are believed to participate in the sensing of saturated and unsaturated fatty acids.”
Backgroundβ‐Cell signalling and insulin secretagogues: A path for improved diabetes therapy
Seino, S., Sugawara, K., Yokoi, N., & Takahashi, H. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12995 · Cited by 79
“GPR40, a member of the GPCR family, was identified as a receptor for fatty acids in 2003.(59,60) GPR40 is expressed at high levels in pancreatic β-cells, and mediates amplification of insulin secretion by long chain fatty acids in a glucosedependent manner.”
BackgroundYamada, H., Yoshida, M., Ito, K., Dezaki, K., Yada, T., Ishikawa, S.-E., & Kakei, M. (2016) · Scientific Reports · doi:10.1038/srep25912 · Cited by 81
Williams, K. J., & Wu, X. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.004 · Cited by 87
Butyrate-induced GPR41 Activation Inhibits Histone Acetylation and Cell Growth
Wu, J., Zhou, Z., Hu, Y., & Dong, S. (2012) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2012.05.008 · Cited by 89
Wang, F., Liu, D., Wang, H., Luo, C., Zheng, M., Liu, H., Zhu, W., Luo, X., Zhang, J., & Jiang, H. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200264h · Cited by 80
Xie, K., Miles, E. A., & Calder, P. C. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.03.003 · Cited by 89
“β-cells (Briscoe et al., 2003; Itoh et al., 2003), while FFA4 activation leads to enhanced”
BackgroundIntestinal microbial metabolites in human metabolism and type 2 diabetes
Herrema, H., & Niess, J. H. (2020) · Diabetologia · doi:10.1007/s00125-020-05268-4 · Cited by 87
Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes
Riedel, M. J., Steckley, D., & Light, P. E. (2004) · Human Genetics · doi:10.1007/s00439-004-1216-5 · Cited by 80
Free Fatty Acid Receptors in Enteroendocrine Cells
Lu, V. B., Gribble, F. M., & Reimann, F. (2018) · Endocrinology · doi:10.1210/en.2018-00261 · Cited by 76
Intake of ω-6 Polyunsaturated Fatty Acid-Rich Vegetable Oils and Risk of Lifestyle Diseases
Yamashima, T., Ota, T., Mizukoshi, E., Nakamura, H., Yamamoto, Y., Kikuchi, M., Yamashita, T., & Kaneko, S. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa072 · Cited by 85
Persistent organic pollutants and β-cell toxicity: a comprehensive review
Hoyeck, M. P., Matteo, G., MacFarlane, E. M., Perera, I., & Bruin, J. E. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00358.2021 · Cited by 87
Sankoda, A., Harada, N., Iwasaki, K., Yamane, S., Murata, Y., Shibue, K., Thewjitcharoen, Y., Suzuki, K., Harada, T., Kanemaru, Y., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00090 · Cited by 85
“Recently, GPR120 (free fatty acid receptor 4) and GPR40 (free fatty acid receptor 1) were identified as major long-chain free fatty acid (LCFA) receptors (11, 12).”
BackgroundCucchi, D., Camacho‐Muñoz, D., Certo, M., Pucino, V., Nicolaou, A., & Mauro, C. (2020) · Cell Stress · doi:10.15698/cst2020.01.209 · Cited by 83
“Fatty acids bind to several surface receptor members of the family of G protein coupled receptors (GPCR) [12, 13].”
BackgroundThe Action and Mode of Binding of Thiazolidinedione Ligands at Free Fatty Acid Receptor 1
Smith, N. J., Stoddart, L. A., Devine, N. M., Jenkins, L., & Milligan, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012849 · Cited by 85
Epidermal growth factor increases insulin secretion and lowers blood glucose in diabetic mice
Lee, H. Y., Yea, K., Kim, J., Lee, B. D., Chae, Y. C., Kim, H. S., Lee, D., Kim, S., Cho, J. ‐., Jin, C. J., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00169.x · Cited by 83
“Insulin secretion can sometimes be regulated through classical signalling cascades involving transmembrane receptors, heterotrimeric G-proteins and second messengers [36–38].”
BackgroundMethodChen, C., Chmelova, H., Cohrs, C. M., Chouinard, J. A., Jahn, S. R., Stertmann, J., Uphues, I., & Speier, S. (2016) · Diabetes · doi:10.2337/db15-1718 · Cited by 82
“Higher fasting insulin has also been observed in other mouse models of T2D (39) and is most likely due to an increased glucose sensitivity of b-cells in the presence of elevated free fatty acid levels (40).”
BackgroundYonezawa, T., Haga, S., Kobayashi, Y., Katoh, K., & Obara, Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.190 · Cited by 82
Sassmann, A., Gier, B., Gröne, H.-J., Drews, G., Offermanns, S., & Wettschureck, N. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41541 · Cited by 75
“Interestingly, β cells express in addition to M3 a wide variety of other potentially Gq/G11-coupled receptors (19–21), and most of these receptors have been shown to be involved in the potentiation of insulin secretion, such as receptors for fatty acids (22), cholecystokinin (23), arginine vasopressin (24, 25), endoth…”
BackgroundFujita, T., Matsuoka, T., Honda, T., Kabashima, K., Hirata, T., & Narumiya, S. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.123 · Cited by 83
“GPR40, a Gi- and Gq-coupled GPCR, is a recently deorphanized long-chain free fatty acid receptor (Itoh et al., 2003).”
BackgroundExploring the Subtleties of Drug−Receptor Interactions: The Case of Matrix Metalloproteinases
Bertini, I., Calderone, V., Fragai, M., Giachetti, A., Loconte, M., Luchinat, C., Maletta, M., Nativi, C., & Yeo, K. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja065156z · Cited by 80
The effect of neurogenin3 deficiency on pancreatic gene expression in embryonic mice
Petri, A., Ahnfelt-Rønne, J., Frederiksen, K. S., Edwards, D. G., Madsen, D., Serup, P., Fleckner, J., & Heller, R. S. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02096 · Cited by 76
“It is well known that insulin secretion is triggered by Ca2C influx through voltage-dependent Ca2C channels (reviewed in (Mears 2004)) and recently G-protein-coupled receptor signalling has been shown to influence insulin secretion (Briscoe et al. 2003, Itoh et al. 2003).”
BackgroundNegoro, N., Sasaki, S., Mikami, S., Ito, M., Tsujihata, Y., Ito, R., Suzuki, M., Takeuchi, K., Suzuki, N., Miyazaki, J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300170m · Cited by 72
Graciano, M. F. R., Valle, M. M. R., Kowluru, A., Curi, R., & Carpinelli, Â. R. (2011) · Islets · doi:10.4161/isl.3.5.15935 · Cited by 79
O’Connell, T. D., Block, R., Huang, S., & Shearer, G. C. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.12.003 · Cited by 83
Ochiai, Y., Uchida, Y., Ohtsuki, S., Tachikawa, M., Aizawa, S., & Terasaki, T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13943 · Cited by 86
“It has been reported that the efficacy of DHA biosynthesis in the liver was increased when the DHA concentration was reduced in the body (Rapoport and Igarashi 2009), and DHA has been reported to facilitate insulin secretion via GPR40 in the pancreas (Itoh et al. 2003).”
BackgroundEpicardial adipose tissue as a mediator of cardiac arrhythmias
Patel, K. H. K., Hwang, T., Liebers, C. S., & Ng, F. S. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00565.2021 · Cited by 83
G protein-coupled receptors for free fatty acids
Milligan, G., Stoddart, L. A., & Brown, A. J. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.03.011 · Cited by 76
Produit-Zengaffinen, N., Davis‐Lameloise, N., Perreten, H., Bécard, D., Gjinovci, A., Keller, P. A., Wollheim, C. B., Herrera, P. L., Muzzin, P., & Assimacopoulos‐Jeannet, F. (2006) · Diabetologia · doi:10.1007/s00125-006-0499-6 · Cited by 90
“Similar amplification was measured in islets from control and transgenic mice, indicating that fatty acids did not activate UCP2 or that the potent effect of fatty acids on the fatty acid receptor GPR 40 [29] or of fatty acyl CoA on the secretory process [30] overcame possible changes in glucose-induced ATP production.”
BackgroundPolyunsaturated fatty acids and type 2 diabetes: Impact on the glycemic control mechanism
Coelho, O. G. L., da Silva, B. P., Rocha, D. M. U. P., Lopes, L. L., & Alfenas, R. D. C. G. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1130016 · Cited by 81
TRPM5 is critical for linoleic acid-induced CCK secretion from the enteroendocrine cell line, STC-1
Shah, B. P., Pin, L., Yu, T., Hansen, D. R., & Gilbertson, T. A. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00209.2011 · Cited by 75
“These include the fatty acid-binding protein CD36 (12) and several GPCRs including GPR40, GPR41, GPR43, GPR84, and GPR120 that have been identified as receptors for FFAs and shown to mediate various FFA-induced regulatory functions in different tissues (2, 3, 8, 10, 13, 22, 27, 29).”
BackgroundWagner, R. J., Kaiser, G., Gerst, F., Christiansen, E., Due‐Hansen, M. E., Grundmann, M., Machicao, F. E., Peter, A., Kostenis, E., Ulven, T., et al. (2013) · Diabetes · doi:10.2337/db12-1249 · Cited by 77
Bjursell, M., Xu, X., Admyre, T., Böttcher, G., Lundin, S., Nilsson, R. G., Stone, V. M., Morgan, N. G., Lam, Y. Y., Storlien, L. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114942 · Cited by 81
“Long chain fatty acids (LCFAs) are preferred ligands for GPR120 [2, 9, 10] [5, 11].”
BackgroundJoseph, J. W., Odegaard, M. L., Ronnebaum, S. M., Burgess, S. C., Muehlbauer, J., Sherry, A. D., & Newgard, C. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706080200 · Cited by 72
Milligan, G., Alvarez‐Curto, E., Watterson, K. R., Ulven, T., & Hudson, B. D. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12879 · Cited by 76
“By contrast with these findings, expression of FFA1 receptors in the pancreas was rapidly linked to the capacity of free fatty acids to acutely amplify glucose-stimulated insulin secretion (Itoh et al., 2003; Salehi et al., 2005).”
ResultGPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells
Park, S.-K., Herrnreiter, A. M., Pfister, S. L., Gauthier, K. M., Falck, B., Falck, J. R., & Campbell, W. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001297 · Cited by 76
“In cells overexpressing GPR40, 11,12- and 8,9-EET also stimulate an increase in intracellular calcium in micromolar concentrations as do long chain free fatty acids (32, 38).”
BackgroundInfluentialToledo, A. P., Reyna‐Jeldes, M., Ortega, L., Coddou, C., & Yévenes, G. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105390 · Cited by 79
Hass, N., Schwarzenbacher, K., & Breer, H. (2007) · Histochemistry and Cell Biology · doi:10.1007/s00418-007-0325-3 · Cited by 75
“G-protein coupled receptors activated by fatty acid ligands are involved in a variety of metabolic processes in diVerent cell types (Itoh et al. 2003; Le Poul et al. 2003; Hirasawa et al. 2005; Salehi et al. 2005; Covington et al. 2006).”
BackgroundFex, M., Nitert, M. D., Wierup, N., Sundler, F., Ling, C., & Mulder, H. (2006) · Diabetologia · doi:10.1007/s00125-006-0464-4 · Cited by 78
“The fact that beta cells express G-protein-coupled receptors that utilise NEFA as ligands, the GPR 40 family [27–29], raises the possibility that receptormediated events triggered by lipids account, at least partially, for the mitochondrial adaptation.”
BackgroundChristiansen, E., Hansen, S. V. F., Urban, C., Hudson, B. D., Wargent, E. T., Grundmann, M., Jenkins, L., Zaibi, M. S., Stocker, C. J., Ullrich, S., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000673 · Cited by 74
Characterization of Gpr101 expression and G-protein coupling selectivity
Bates, B., Zhang, L., Nawoschik, S. P., Kodangattil, S. R., Tseng, E., Kopsco, D. C., Kramer, A., Shan, Q., Taylor, N., Johnson, J., et al. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.123 · Cited by 79
Han, T., Yu, C., Tian, S., Wang, L., Liang, X., Duan, W., Na, L., & Sun, C. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0469-3 · Cited by 72
“Moreover, FFA forms from hydrolysis of TG can cross β-cell membrane and active β-cell surface fatty acids receptor, which causes an increase in intracellular Ca2+, leading to increased insulin secretion [39, 40].”
BackgroundYamada, M., Takahashi, N., Matsuda, Y., Sato, K., Yokoji, M., Sulijaya, B., Maekawa, T., Ushiki, T., Mikami, Y., Hayatsu, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27408-y · Cited by 76
Qin, W.-P., Cao, L.-Y., Li, C.-H., Guo, L.-H., Colbourne, J., & Ren, X.-M. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.9b07295 · Cited by 71
Klett, E. L., Chen, S., Edin, M. L., Li, L. O., Ilkayeva, O., Zeldin, D. C., Newgard, C. B., & Coleman, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.481077 · Cited by 70
Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease
Secor, J. D., Fligor, S. C., Tsikis, S. T., Yu, L. J., & Puder, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.656441 · Cited by 81
Metadata
- Authors
- Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., Tanaka, H., Maruyama, M., Satoh, R., Okubo, S., Kizawa, H., Komatsu, H., Matsumura, F., Noguchi, Y., Shinohara, T., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- ORCID
- Venue
- Nature
- Published
- 2003-02-23
- Volume
- 422
- Issue
- 6928
- Pages
- 173-176
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2128326754
- Cited by
- 1,538
- References
- 26
- Citations by year
- 2026: 21 · 2025: 50 · 2024: 54 · 2023: 51 · 2022: 58 · 2021: 89 · 2020: 74 · 2019: 75 · 2018: 88 · 2017: 89 · 2016: 111 · 2015: 82 · 2014: 84 · 2013: 91 · 2012: 84
- FWCI
- 45.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- free fatty acids, GPR40, insulin secretion, pancreatic beta cells, glucose-stimulated insulin secretion, long-chain fatty acids, G protein-coupled receptors, diabetes mellitus, antidiabetic drug development
- MeSH terms
- Insulin Secretion, Animals, Haplorhini, Calcium, Enzyme Activation, Fatty Acids, Nonesterified, Glucose, Cricetinae, Humans, Insulin, Male, Molecular Sequence Data, Pancreas, Receptors, Cell Surface, RNA, Messenger, Transfection, CHO Cells, Rats, Wistar, Calcium Signaling, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, RNA, Small Interfering, Receptors, G-Protein-Coupled, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.